GMO Emerging Markets Fund Class R6
Limited financial coverage for GEMNX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Under normal circumstances, the fund invests at least 80% of the fund’s net assets directly and indirectly (e. g. , through underlying funds or derivatives) in companies tied economically to markets that are not treated as “developed markets in the MSCI World Index (“emerging markets”).
- IPO
- 2020
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on GEMNX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $516.84M
- Div Yield
- 5.48%
- 52W High
- $42.52
- 52W Low
- $28.75
- 50D MA
- $39.75
- 200D MA
- $35.80
- Beta
- 1.08
- RSI (14)
- 60
- Avg Volume
- 0
No earnings-call transcripts are available for GEMNX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 12.33M
- Float Shares
- 0
Our GEMNX coverage
Recent articles, reports, and earnings notes.
No research on GEMNX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GEMNX report →